Point72 Hong Kong LTD Kymera Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $279,754 - $458,498	13,379 New	13,379 $291,000
Q2 2022 Aug 15, 2022	SELL	$14.13 - $42.55 $17,846 - $53,740	-1,263 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $44,583 - $81,690	1,263 New	1,263 $53,000
Q2 2021 Aug 16, 2021	SELL	$31.08 - $51.95 $16,099 - $26,910	-518 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $18,461 - $44,268	518 New	518 $20,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.22B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.